JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Issues journals
Medical Radiology and Radiation Safety. 2022. Vol. 67. № 4
Risk Factors for Arterial Hypertension (Literature Review)
K.V. Briks
Southern Urals Biophysics Institute, Ozyorsk, Chelyabinsk region, Russia
Contact person: K.V. Briks, This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
The review provides up-to-date data on effects of non-modifiable (sex, age) and modifiable (smoking, alcohol consumption, obesity, vitamin D deficiency, marital status, physical activity, depression) non-radiation risk factors on incidence risks of arterial hypertension. The review also refers to scientific evidence of the impact of ionizing radiation on arterial hypertension.
Keywords: arterial hypertension, ionizing radiation, risk factors, relative risk, odds ratio, excess relative risk
For citation: Briks KV. Risk Factors for Arterial Hypertension (Literature Review). Medical Radiology and Radiation Safety. 2022;67(4):24-35. DOI: 10.33266/1024-6177-2022-67-4-24-35
References
1. Chazova I.Ye., Zhernakova Yu.V. Diagnosis and Treatment of Arterial Hypertension. Guidelines. Sistemnyye gipertenzii = Systemic hypertension. 2019;16;1:6–31. doi: 10.26442/2075082X.2019.1.190179 (In Russ.).
2. NCD Risk Factor Collaboration (NCD-RisC). Worldwide Trends in Blood Pressure from 1975 to 2015: a Pooled Analysis of 1479 Population-Based Measurement Studies with 19,1 Million Participants. The Lancet. 2017;389;10064:37–55. doi: 10.1016/S0140-6736(16)31919-5.
3. Forouzanfar M.H., Liu P., Roth G.A., Ng M., Biryukov S., Marczak L., et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990–2015. Jama. 2017;317;2:165–182. doi:10.1001/jama.2016.19043.
4. Chow C.K., Teo K.K., Rangarajan S., Islam S., Gupta R., Avezum A., et al. Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries. Jama. 2013;310;9:959–968. doi:10.1001/jama.2013.184182.
5. Kearney P.M., Whelton M., Reynolds K., Whelton P.K., He J. Worldwide Prevalence of Hypertension: a Systematic Review. J. Hypertens. 2004;22;1:11–19.
6. Ettehad D., Emdin C.A., Kiran A., Anderson S.G., Callender T., Emberson J., et al. Blood Pressure Lowering for Prevention of Cardiovascular Disease and Death: a Systematic Review and Meta-Analysis. The Lancet. 2016;87;10022:957–967. doi: 10.1016/S0140-6736(15)01225-8.
7. Lip G.Y.H., Coca A., Kahan T., Boriani G., Manolis A.S., Olsen M.H., et al. Hypertension and Cardiac Arrhythmias: Executive Summary of a Consensus Document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, Endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). European Heart Journal–Cardiovascular Pharmacotherapy. 2017;3;4:235–250. doi: 10.1093/ehjcvp/pvx019.
8. Gottesman R.F., Albert M.S., Alonso A., Coker L.H., Coresh J., Davis S.M., et al. Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort. JAMA Neurology. 2017;74;10:1246–1254. doi: 10.1001/jamaneurol.2017.1658.
9. Vishram J.K., Borglykke A., Andreasen A.H., Jeppesen J., Ibsen H., Jørgensen T., et al. Impact of Age on the Importance of Systolic and Diastolic Blood Pressures for Stroke Risk: the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project. Hypertension. 2012;60;5:1117–1123. doi: 10.1161/HYPERTENSIONAHA.112.201400.
10. Almagro P., Cabrera F.J., Diez J. Comorbidities and Shortterm Prognosis in Patients Hospitalized for Acute Exacerbation of COPD. The ESMI Study. Chest. 2012;142;5:1126–1133. doi: 10.1378/chest.11-2413.
11. Park H.J., Leem A.Y., Lee S.H., Song J.H., Park M.S., Kim Y.S., et al. Comorbidities in Obstructive Lung Disease in Korea: Data from the Fourth and Fith Korean National Health and Nutrition Examination Survey. Int. J. Chron Obstruct Pulmon Dis. 2015;10:1571–1582. doi: 10.1378/chest.11-2413.
12. Hillas G., Perlikos F., Tsiligianni I., Tzanakis N. Managing Comorbidities in COPD. Int. J. Chron Obstruct Pulmon Dis. 2015;10:95–109. doi: 10.2147/COPD.S54473.
13. Rabahi M.F., Pereira S.A., Silva Júnior J.L., de Rezende A.P., Castro da Costa A., de Sousa Corrêa K., et al. Prevalence of Chronic Obstructive Pulmonary Disease among Patients with Systemic Arterial Hypertension Without Respiratory Symptoms. Int. J. Chron Obstruct Pulmon Dis. 2015;10:1525–1529. doi: 10.2147/COPD.S85588.
14. Portegies M.L., Lahousse L., Joos G.F., Hofman A., Koudstaal P.J., Stricker B.H., et al. Chronic Obstructive Pulmonary Disease and the Risk of Stroke: the Rotterdam Study. Am. J. Respir Crit. Care Med. 2016;193;3:251–258. doi: 10.1164/rccm.201505–0962OC.
15. Gasparini A., Evans M., Coresh J., Grams M.E., Norin O., Qureshi A.R., et al. Prevalence and Recognition of Chronic Kidney Disease in Stockholm Healthcare. Nephrol. Dial. Transplant. 2016;31;12:2086-2094. doi: 10.1093/ndt/gfw354.
16. Hong J.W., Noh J.H., Kim D.J. Factors Associated with High Sodium Intake Based on Estimated 24-Hour Urinary Sodium Excretion: the 2009–2011 Korea National Health and Nutrition Examination Survey. Medicine (Baltimore). 2016;95;9:2864. doi: 10.1097/MD.0000000000002864.
17. Acuña L., Sánchez P., Soler L.A., Alvis L.F. Kidney Disease in Colombia: Priority for Risk Management. Rev. Panam. Salud Publica. 2016;40;1:16–22. PMID: 27706391.
18. Novikova D.S., Popkova T.V., Nasonov Ye.L. Arterial Hypertension in Rheumatoid Arthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2011;3:52–68 (In Russ.).
19. Folomeyeva O.M., Nasonov Ye.L., Andrianova I.A., Galushko Ye.A., Goryachev D.V., Dubinina T.V., et al. Rheumatoid Arthritis in Rheumatological Care of Russia: The Severity of the Disease in a Russian Patient Population: a Cross-Sectional Epidemiological Study (Raiser). Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2010;1:50–60 (In Russ.).
20. Nikitina N.M., Rebrov A.P. Determining the Risk of Developing Cardiovascular Disease in Patients with Rheumatoid Arthritis. Terapevticheskiy Arkhiv = Therapeutic Archive. 2009;82;6:29–33 (In Russ.).
21. Nasonov Ye.L., Popkova T.V. Cardiovascular Problems of Rheumatology. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2004;4:4–9 (In Russ.).
22. Gonzalez A., Maradit Kremers H., Crowson C.S., Ballman K.V., Roger V.L., Jacobsen S.J., et al. Do Cardiovascular Risk Factors Confer the Same Risk for Cardiovascular Outcomes in Rheumatoid Arthritis Patients as in Non-Rheumatoid Arthritis Patients? Ann. Rheum. Dis. 2008;67;1:64–69. doi: 10.1136/ard.2006.059980.
23. Chung C.P., Oeser A., Solus J.F., Avalos I., Gebretsadik T., Shintani A., et al. Prevalence of the Metabolic Syndrome is Increased in Rheumatoid Arthritis and is Associated with Coronary Atherosclerosis. Atherosclerosis. 2008;196;2:756–763. doi: 10.1016/j.atherosclerosis.2007.01.004.
24. Panoulas V.F., Douglas K.M., Milionis H.J., Nightingale P., Kita M.D., Klocke R., et al. Serum Uric Acid is Independently Associated with Hypertension in Patients with Rheumatoid Arthritis. J. Hum. Hypertens. 2008;22;3:177–182. doi: 10.1038/sj.jhh.1002298.
25. Del Rincón I., Freeman G.L., Haas R.W., O'Leary D.H., Escalante A. Relative Contribution of Cardiovascular Risk Factors and Rheumatoid Arthritis Clinical Manifestations to Atherosclerosis. Arthritis Rheum. 2005;52;11:3413–3423. doi: 10.1002/art.21397.
26. Dessein P.H., Joffe B.I., Stanwix A.E., Christian B.F., Veller M. Glucocorticoids and Insulin Sensitivity in Rheumatoid Arthritis. J. Rheumatol. 2004;31;5:867–874. PMID: 15124244.
27. Zhao Q., Hong D., Zhang Y., Sang Y., Yang Z., Zhang X. Association between Anti-TNF Therapy for Rheumatoid Arthritis and Hypertension: a Meta-Analysis of Randomized Controlled Trials. Medicine. 2015;94;14:e731. doi: 10.1097/MD.0000000000000731.
28. Avina-Zubieta J.A., Thomas J., Sadatsafavi M., Lehman A.J., Lacaille D. Risk of Incident Cardiovascular Events in Patients with Rheumatoid Arthritis: a Meta-Analysis of Observational Studies. Ann. Rheum Dis. 2012;71;9:1524–1529. doi: 10.1136/annrheumdis-2011-200726.
29. Choi H.K., Soriano L.C., Zhang Y., Rodríguez L.A. Antihypertensive Drugs and Risk of Incident Gout among Patients with Hypertension: Population Based Case-Control Study. BMJ. 2012;344:d8190. doi: 10.1136/bmj.d8190.
30. McAdams DeMarco M.A., Maynard J.W., Baer A.N., Gelber A.C., Young J.H., Alonso A., Coresh J. Diuretic Sue, Increased Serum Urate Levels, and Risk of Incident Gout in a Population‐Based Study of Adults with Hypertension: The Atherosclerosis Risk in Communities Cohort Study. Arthritis & Rheumatism. 2012;64;1:121–129. doi: 10.1002/art.33315.
31. Abeles A.M. Hyperuricemia, Gout, and Cardiovascular Disease: an Update. Current Rheumatology Reports. 2015;17;3:13. doi: 10.1007/s11926-015-0495-2.
32. McAdams-DeMarco M.A., Maynard J.W., Baer A.N., Coresh J. Hypertension and the Risk of Incident Gout in a Population‐Based Study: the Atherosclerosis Risk in Communities Cohort. The Journal of Clinical Hypertension. 2012;14;10:675–679. doi: 10.1111/j.1751-7176.2012.00674.x.
33. Xu W., Huang Y., Li L., Sun Z., Shen Y., Xing J., et al. Hyperuricemia Induces Hypertension Through Activation of Renal Epithelial Sodium Channel (ENaC). Metabolism. 2016;65;3:73–83. doi: 10.1016/j.metabol.2015.10.026.
34. Vaidya V., Gangan N., Sheehan J. Impact of Cardiovascular Complications among Patients with Type 2 Diabetes Mellitus: a Systematic Review. Expert Review of Pharmacoeconomics & Outcomes Research. 2015;15;3:487–497. doi: 10.1586/14737167.2015.102466.
35. De Boer I.H., Bangalore S., Benetos A., Davis A.M., Michos E.D., Muntner P., et al. Diabetes and Hypertension: a Position Statement by the American Diabetes Association. Diabetes Care. 2017;40;9:1273–1284. doi: 10.2337/dci17-0026.
36. Petrie J.R., Guzik T.J., Touyz R.M. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Canadian Journal of Cardiology. 2018;34;5:575–584. doi: 10.1016/j.cjca.2017.12.005.
37. Ntaios G., Vemmos K., Lip G.Y., Koroboki E., Manios E., Vemmou A., et al. Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source. Stroke. 2016;47;9:2278–2285. doi: 10.1161/STROKEAHA.116.013713.
38. Derakhshan A., Bagherzadeh-Khiabani F., Arshi B., Ramezankhani A., Azizi F., Hadaegh F. Different Combinations of Glucose Tolerance and Blood Pressure Status and Incident Diabetes, Hypertension, and Chronic Kidney Disease. J. Am. Heart Assoc. 2016;5;8:e003917. doi: 10.1161/JAHA.116.003917.
39. Sarwar N., Gao P., Seshasai S.R. Diabetes Mellitus, Fasting Blood Glucose Concentration, and Risk of Vascular Disease: a Collaborative Meta-Analysis of 102 Prospective Studies. Lancet. 2010;375;9733:2215–2222. doi: 10.1016/S0140-6736(10)60484-9.
40. Oshchepkova Ye.V., Lazareva N.V., Chazova I.Ye. Quality Assessment of Examination of Patients with Arterial Hypertension in Primary Health Care (According to the Russian Arterial Hypertension Register Data). Sistemnyye Gipertenzii = Systemic Hypertension. 2017;14;2:29–34. (In Russ.). doi: 10.26442/2075-082X_14.2.29-34.
41. Vera G., Nataša D., Svetlana K., Sonja S., Jasmina G., Sonja T. Epidemiology of Hypertension in Serbia: Results of a National Survey. Journal of Epidemiology. 2012;22;3:261–266. doi: 10.2188/jea.JE20110077.
42. Cutler J.A., Sorlie P.D., Wolz M., Thom T., Fields L.E., Roccella E.J. Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults between 1988–1994 and 1999–2004. J. Hypertension. 2008;52;5:818–827. doi: 10.1161/HYPERTENSIONAHA.108.113357.
43. Cheng S., Xanthakis V., Sullivan L.M., Vasan R.S. Blood Pressure Tracking over the Adult Life Course:Patterns and Correlates in the Framingham Study. Hypertension. 2012;60;6:1393–1399. doi: 10.1161/HYPERTENSIONAHA.112.201780.
44. Wright J.D., Hughes J.P., Ostchega Y., Yoon S.S., Nwankwo T. Mean Systolic and Diastolic Blood Pressure in Adults Aged 18 and over in the United States, 2001–2008. National Center Health Statistics Reports. 2011;35:24. PMID: 21485611.
45. Yoon S.S., Fryar C.D., Carroll M.D. Hypertension Prevalence and Control among Adults: United States, 2011-2014. NCHS Data Brief. 2015;220:1–8. PMID: 26633197.
46. Chow C.K., Teo K.K., Rangarajan S., Islam S., Gupta R., Avezum A., et al. Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries. Jama. 2013;310;9:959–968. doi: 10.1001/jama.2013.184182.
47. Writing Group Members, Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K., Blaha M.J., Cushman M., et al. Executive Summary: Heart Disease and Stroke Statistics – 2016 Update: A Report From the American Heart Association. Circulation. 2016;133;4:447. doi: 10.1161/CIR.0000000000000366.
48. Vishnevskiy A., Andreyev Ye., Timonin S. Mortality from Cardiovascular Diseases and Life Expectancy in Russia. Demograficheskoye Obozreniye = Demographic Review. 2016;3;1:6–34 (In Russ.).
49. Vasan R.S., Beiser A., Seshadri S., Larson M.G., Kannel W.B., D'Agostino R.B., Levy D. Residual Life Time Risk for Developing Hypeгtension in Middleaged Women and Men: The Frarningham Неагt Study. JАМА. 2002;287;8:1003–1010. doi: 10.1001/jama.287.8.1003.
50. Boytsov S.A., Balanova Yu.A., Shalnova S.A., Deyev A.D., Artamonova G.V., Gatagonova T.M., et al. Arterial Hypertension among Individuals of 25-64 Years Old: Prevalence, Awareness, Treatment and Control. By the Data from ECCD. Kardiovaskulyarnaya Terapiya i Profilaktika = Cardiovascular Therapy and Prevention 2014;14;4:4–14 (In Russ.).
51. Ibragimova Kh.I., Mammayev S.N., Omarova D.A. Gender-Specific Regulation of Blood Pressure and Antihypertensive Treatment. Arterialnaya Gipertenziya = Arterial Hypertension. 2018;24;3:303–308 (In Russ.). doi: 10.18705/1607-419X-2018-24-3- 303-308
52. Danaei G., Finucane M.M., Lin J.K. National, Regional, and Global Trends in Systolic Blood Pressure Since 1980: Systematic Analysis of Health Examination Surveys and Epidemiological Studies with 786 Country-Years and 5,4 Million Participants. Lancet. 2011;377;9765:568–577. doi: 10.1016/S0140-6736(10)62036-3.
53. Thacker E.L., Gillett S.R., Wadley V.G., Unverzagt F.W., Judd S.E., McClure L.A., et al. The American Heart Association Life’s Simple 7 and Incident Cognitive Impairment: the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. J. Am. Heart. Assoc. 2014;3;3:e000635. doi: 10.1161/JAHA.113.000635.
54. Crim M.T., Yoon S.S., Ortiz E., Wall H.K., Schober S., Gillespie C., et al. National Surveillance Definitions for Hypertension Prevalence and Control among Adults. Circ. Cardiovasc Qual. Outcomes. 2012;5;3:343–351. doi: 10.1161/CIRCOUTCOMES.111.963439.
55. Nwankwo T., Yoon S.S., Burt V., Gu Q. Hypertension among Adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. NCHS Data Brief. 2013;133:1–8. PMID: 24171916.
56. Linneberg A., Jacobsen R.K., Skaaby T., Taylor A.E., Fluharty M.E., Jeppesen J.L., et al. Effect of Smoking on Blood Pressure and Resting Heart Rate: a Mendelian Randomization Meta-Analysis in the CARTA Consortium. Circulation: Cardiovascular Genetics. 2015;8;6:832–841. doi: 10.1161/CIRCGENETICS.115.001225.
57. Liu X., Byrd J.B. Cigarette Smoking and Subtypes of Uncontrolled Blood Pressure among Diagnosed Hypertensive Patients: Paradoxical Associations and Implications. American Journal of Hypertension. 2017;30;6:602–609. doi: 10.1093/ajh/hpx014.
58. Seven E., Husemoen L.L., Wachtell K., Ibsen H., Linneberg A., Jeppesen J.L. Five-Year Weight Changes Associate with Blood Pressure Alterations Independent of Changes in Serum Insulin. Journal of Hypertension. 2014;32;11:2231–2237. doi: 10.1097/HJH.0000000000000317.
59. Shtarik S.Yu. Connection between Alcohol Consumption and Arterial Hypertension. Byulleten Sibirskogo Otdeleniya Rossiyskoy Akademii Meditsinskikh Nauk. 2010;30;5:25–29 (In Russ.).
60. Balabina N.M., Baglushkina S.Yu. The Use of Alcohol and Arterial Pressure. Sibirskiy Meditsinskiy Zhurnal = The Siberian Medical Journal. 2012;110;3:20–22 (In Russ.).
61. Fan A.Z., Russell M., Stranges S., Dorn J., Trevisan M. Association of Lifetime Alcohol Drinking Trajectories with Cardiometabolic Risk. J. Clin. Endocrinol. Metab. 2008;93;1:154–161. doi: 10.1210/jc.2007-1395.
62. Druzhilov M.A., Druzhilova O.Yu., Beteleva Yu.Ye., Kuznetsova T.Yu. Obesity as Cardiovascular Risk Factor: Accent on Quality and Functional Activity of Adipose Tissue. Rossiyskiy Kardiologicheskiy Zhurnal = Russian Journal of Cardiology. 2015;20;4:111–117 (In Russ.). doi: 10.15829/1560-4071-2015-04-111-117.
63. Xin X., He J., Frontini M.G., Ogden L.G., Motsamai O.I., Whelton P.K. Effects of Alhohol Reduction on BP: a Meta-Analysis of Randomized Controlled Trials. Hypertension. 2001;38:1112–1117. doi: 10.1161/hy1101.093424.
64. Shalnova S.A., Konradi A.O., Balanova Yu.A., Deyev A.D., Imayeva A.E., Muromtseva G.A., et al. What Factors Do Influence Arterial Hypertension Control in Russia. Kardiovaskulyarnaya Terapiya i Profilaktika = Cardiovascular Therapy and Prevention. 2018;17;4:53–60 (In Russ.). doi: 10.15829/1728-8800-2018-4-53-60.
65. Drapkina O.M., Chaparkina S.O. Interrelation of Metabolic Syndrome, Aseptic Inflammation and Endothelial Dysfunction. Rossiyskiye Meditsinskiye Vesti. 2007;12;3:67–76 (In Russ).
66. Lee Y. Indices of Abdominal Obesity Are Better Discriminators of Cardiovascular Risk Factors Than BMi: a Meta-Analysis. Journal of Clinical Epidemiology. 2008;61:646–53. doi: 10.1016/j.jclinepi.2007.08.012.
67. Kumar S., Sharma V. Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival: the Cardiovascular Disease Lifetime Risk Pooling Project in New Delhi, India. Atherosclerosis. 2017;263:e159. doi: 10.1016/j.atherosclerosis.2017.06.504.
68. Hall J.E., do Carmo J.M., da Silva A.A., Wang Z., Hall M.E. Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms. Circulation research. 2015;116;6:991–1006. doi: 10.1161/CIRCRESAHA.116.305697.
69. Shalnova S.A., Deyev A.D., Balanova Yu.A., Kapustina A.V., Imayeva A.E., Muromtseva G.A., et al. Twenty Years Trends of Obesity and Arterial Hypertension and Their Association in Russia. Kardiovaskulyarnaya Terapiya i Profilaktika = Cardiovascular Therapy and Prevention. 2017;16;4:4–10. (In Russ.). doi: 10.15829/1728-8800-2017-4-4-10.
70. Tian S., Dong G.H., Wang D., Liu M.M., Lin Q., Meng X.J., et al. Factors Associated with Prevalence, Awareness, Treatment and Control of Hypertension in Urban Adults from 33 Communities in China: the CHPSNE Study. Hypertension Research. 2011;34;10:1087. doi:10.1038/hr.2011.99.
71. Sakboonyarat B., Mungthin M. Prevalence and Associated Factors of Uncontrolled Hypertension among Thai Patients with Hypertension: A Nationwide Cross-Sectional Survey. Rev. Epidemiol. Sante Publique. Elsevier Masson. 2018;66:S310–S311. doi: 10.1016/J.RESPE.2018.05.194.
72. Hippisley-Cox J., Coupland C., Pringle M., Crown N., Hammersley V. Married Couples’ Risk of Same Disease: Cross Sectional Study. BMJ. 2002;325;7365:636–640. doi: 10.1136/bmj.325.7365.636.
73. Di Castelnuovo A., Quacquaruccio G., Donati M.B., de Gaetano G., Iacoviello L. Spousal Concordance for Major Coronary Risk Factors: A Systematic Review and Meta-Analysis. Am. J. Epidemiol. 2009;169;1:1–8. doi: 10.1093/aje/kwn234.
74. Qi D., Nie X.L., Wu S., Cai J. Vitamin D and Hypertension: Prospective Study and Meta-Analysis. PloS One. 2017;12;3:e0174298. doi: 10.1371/journal.pone.0174298.
75. Forman J.P., Giovannucci E., Holmes M.D., Bischoff-Ferrari H.A., Tworoger S.S., Willett W.C., et al. Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension. Hypertension. 2007;49;5:1063–1069. doi: 10.1161/HYPERTENSIONAHA.107.087288.
76. Forman J.P., Curhan G.C., Taylor E.N. Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension among Young Women. Hypertension. 2008;52;5:828–832. doi: 10.1161/HYPERTENSIONAHA.108.117630.
77. Porrecca E., Di Febbo C., Fusco L., Moretta V., Di Nisio M., Cuccurullo F. Solube Thrombomodulin and Vascular Adhesion Molecule-1 Are Associated to Leptin Plasma Levels in Obese Women. Atherosclerosis. 2004;172;1:175–180. doi: 10.1016/j.atherosclerosis.2003.09.022.
78. Forouhi N.G., Luan J., Cooper A., Boucer B.J., Wareham N.J. Baseline Serum 25-Hydroxy Vitamin D is Predictive of Future Glycemic Status and Insulin Resistance: the Medical Research Council Ely Prospective Study 1990–2000. Diabetes. 2008;57;10:2619–2625. doi: 10.2337/db08–0593.
79. Meng L., Chen D., Yang Y., Zheng Y., Hui R. Depression Increases the Risk of Hypertension Incidence: a Meta-Analysis of Prospective Cohort Studies. J. Hypertens. 2012;30;5:239–243. doi: 10.1097/HJH.0b013e32835080b7.
80. Gafarov V.V., Panov D.O., Gromova Ye.A., Gagulin I.V., Gafarova A.V. Influence of Depression on Risk of Arterial Hypertension in Female 25-64 Years in Open Population. Mir Nauki, Kultury, Obrazovaniya = The World of Science, Culture and Education. 2012;4;35:277–278 (In Russ.).
81. Li Z., Li Y., Chen L., Chen P., Hu Y. Prevalence of Depression in Patients with Hypertension: a Systematic Review and Meta-Analysis. Medicine. 2015;94;31:e1317. doi: 10.1097/MD.0000000000001317.
82. Chobanov R.E., Babayeva A.D., Islamzade I.F. Assessment of the Impact of Correcting of Low Physical Activity on the Effectiveness of Treatment of Hypertension among Women of Reproductive Age in Outpatient Conditions. Vísnik Problem Biologii i Meditsiny = Bulletin of Problems in Biology and Medicine. 2016;1;4:100–104 (In Russ.).
83. Hegde S.M., Solomon S.D. Influence of Physical Activity on Hypertension and Cardiac Structure and Function. Current Hypertension Reports. 2015;17;10:77. doi: 10.1007/s11906-015-0588-3.
84. Diaz K.M., Booth J.N., Seals S.R., Abdalla M., Dubbert P.M., Sims M., et al. Physical Activity and Incident Hypertension in African Americans: the Jackson Heart Study. Hypertension. 2017;69;3:421–427. doi: 10.1161/HYPERTENSIONAHA.116.08398.
85. Chen M., Hu J., McCoy T., Letvak S., Ivanov L. Predicting Changes in Physical Activity and Blood Pressure among Older Adults with Hypertension. Innovation in Aging. 2018;2;Suppl 1:499. doi: 10.1093/geroni/igy023.1857.
86. Börjesson M., Onerup A., Lundqvist S., Dahlöf B. Physical Activity and Exercise Lower Blood Pressure in Individuals with Hypertension: Narrative Review of 27 RCTs. Br. J. Sports Med. 2016;50;6:356–361. doi: 10.1136/bjsports-2015-095786.
87. Larsen M.K., Matchkov V.V. Hypertension and Physical Exercise: the Role of Oxidative Stress. Medicina. 2016;52;1:19–27. doi: 10.1016/j.medici.2016.01.005.
88. Bakker E.A., Sui X., Brellenthin A.G., Lee D.C. Physical Activity and Fitness for the Prevention of Hypertension. Current Opinion in Cardiology. 2018;33;4:394–401. doi: 10.1097/HCO.0000000000000526.
89. Liu X., Zhang D., Liu Y., Sun X., Han C., Wang B., et al. Dose–Response Association between Physical Activity and Incident Hypertension: a Systematic Review and Meta-Analysis of Cohort Studies. Hypertension. 2017;69;5:813–820. doi: 10.1161/HYPERTENSIONAHA.116.08994.
90. Li W., Wang D., Wu C., Shi O., Zhou Y., Lu Z. The Effect of Body Mass Index and Physical Activity on Hypertension among Chinese Middle-Aged and Older Population. Scientific Reports. 2017;7;1:10256. doi: 10.1038/s41598-017-11037-y.
91. Vorobyev Ye.I., Stepanov R.P. Ioniziruyushcheye Izlucheniye i Krovenosnyye Sosudy = Ionizing Radiation and Blood Vessels. Moscow, Energatomizdat Publ., 1985 (In Russ.).
92. Moskalev Yu.I. Otdalennyye Posledstviya Ioniziruyushchikh Izlucheniy = Long-Term Effects of Ionizing Radiation. Moscow, Meditsina Publ., 1991 (In Russ.).
93. Ilin L.A. Radiatsionnaya Meditsina = Radiation Medicine. Moscow, IzdAT Publ., 2001 (In Russ.).
94. Ilin LA., Kirillov VF, Korenkov IP. Radiatsionnaya Meditsina = Radiation Medicine. Moscow, IzdAT Publ., 1999 (In Russ.).
95. Ilin L.A. Tekhnogennoye Oblucheniye i Bezopasnost Cheloveka. Elektronnyy Resurs = Technogenic Radiation and Human Safety. Electronic Resource. Moscow Publ., 2002 (In Russ.).
96. Stavitskiy R.V., Guslistyy V.P., Beridze A.D. Determination of "Small" Doses of AI by Analytical Processing of Blood Parameters. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost = Medical Radiology and Radiation Safety. 1998;43;1:58–61 (In Russ.).
97. Stavitskiy R.V., Lebedev L.A., Mekheyechev A.V., Mikheyenko S.G., Zhanina T.V. Some Items of Low Radiation Dose Effects. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost = Medical Radiology and Radiation Safety. 2003;48;1:30–39 (In Russ.).
98. Stavitskiy R.V., Lebedev L.A., Mekheyechev A.V., Zhanina T.V. Analysis of the Effects of Low-Dose Ionizing Radiation. Meditsinskaya Tekhnika = Biomedical Engineering. 2002;2:37–43 (In Russ).
99. Ryabukhin Yu.S. Low Levels of Ionizing Radiation and Health: a Systematic Approach. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost = Medical Radiology and Radiation Safety. 2000;45;4:5–42. (In Russ.).
100. Kabasheva N.Ya., Okladnikova N.D., Mamakova O.V. Causes of Lethal Outcomes and Morphologic Characteristics of Cardiovascular System in the Long-Term Period after a Chronic Exposure to Radiation. Kardiologiya = Kardiologiia. 2001;11:78. (In Russ.).
101. Tsuya A., Wakano Y., Otake M. Capillary Microscopic Observation Onthe Superficial Minute Vessels of Atomic-Bomb Survivors, 1956–57. 1. Fingernail Fold, Labial Mucosa, and Lingual Mucosa. ABCC TR 23–69. Hiroshima, Japan: Radiation Effects Research Foundation, 1969.
102. Stewart J.R., Cohn K.E., Fajardo L.F., Hancock W.E., Kaplan H.S. Radiation-Induced Heart Disease. A Study of Twenty-Five Patients. Radiology. 1967;89:302–310.
103. Van Cleave C.D. Late Somatic Effects of Ionizing Radiation. Oakridge: U.S. Atomic Energy Commission, Division of Technical Information, 1968.
104. Casarett G.W. Similarities and Contrasts between Radiation and Timepathology. Adv. Gerontol. Res. 1964;1:.109–163.
105. Reinhold H.S. Cell Viability of the Vessel Wall. Curr. Top. Radiat. Res.1974;10:9–28.
106. Little M.P., Zablotska L.B., Brenner A.V., Lipshultz S.E. Circulatory Disease Mortality in the Massachusetts Tuberculosis Fluoroscopy Cohort Study. European Journal of Epidemiology. 2015;31;3:287–309. doi: 10.1007/s10654-015-0075-9.
107. Zablotska L.B., Little M.P., Cornett R.J. Potential Increased Risk of Ischemic Heart Disease Mortality with Significant Dose Fractionation in the Canadian Fluoroscopy Cohort Study. American Journal of Epidemiology. 2013;179;1:120–131. doi: 10.1093/aje/kwt244.
108. Shimizu Y., Kodama K., Nishi N., Kasagi F., Suyama A., Soda M., et al. Radiation Exposure and Circulatory Disease Risk: Hiroshima and Nagasaki Atomic Bomb Survivor Data, 1950 – 2003. BMJ. 2010;340:b5349. doi: 10.1136/bmj.b5349.
109. Takahashi I., Shimizu Y., Grant E.J., Cologne J., Ozasa K., Kodama K. Heart Disease Mortality in the Life Span Study, 1950–2008. Radiation Research. 2017;187;3:319–332. doi: 10.1667/rr14347.1.
110. Yamada M., Lennie Wong F., Fujiwara S., Akahoshi M., Suzuki G. Noncancer Disease Incidence in Atomic Bomb Survivors, 1958–1998. Radiation Research. 2004;161;6:622–632. doi: 10.1667/rr3183.
111. Ivanov V.K., Maksioutov M.A., Chekin S.Y., Petrov A.V., Biryukov A.P., Kruglova Z.G., Kravchenko J.S. The Risk of Radiation-Induced Cerebrovascular Disease in Chernobyl Emergency Workers. Health Physics. 2006;90;3:199–207. doi: 10.1097/01.hp.0000175835.31663.ea.
112. Ivanov V.K., Chekin S.Yu., Maksyutov M.A., Kashcheyev V.V., Karpenko S.V., Tumanov K.A., et al. Radiation Risk of Incidence of Hypertensia among Russian Recovery Operation Workers of the Chernobyl Accident. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost = Medical Radiology and Radiation Safety. 2017;62;1:32–37 (In Russ.). doi: 10.12737/25050.
113. Azizova T., Briks K., Bannikova M., Grigoryeva E. Hypertension Incidence Risk in a Cohort of Russian Workers Exposed to Radiation at the Mayak Production Association Over Prolonged Periods. Hypertension. 2019;73;6:1174–1184. doi: 10.1161/HYPERTENSIONAHA.118.11719.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The author declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors
Article received: 15.03.2022. Accepted for publication: 23.04.2022
Medical Radiology and Radiation Safety. 2022. Vol. 67. № 4
Incidence and Mortality from Central Nervous System Tumors
in the Cohort of Workers Chronically Exposed to Radiation
M.B. Moseeva, T.V. Azizova, M.V. Bannikova
Southern Urals Biophysics Institute of the Federal Medical Biological Agency, Ozyorsk, Russia.
Contact person: Azizova Tamara Vasilievna, This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Purpose: To analyze incidence and mortality rates of central nervous system (CNS) primary tumors (PT) in the cohort of workers chronically exposed to radiation.
Material and methods: Study cohort included 22237 Mayak Production Association workers. Work history data and dose estimates from the “Mayak Worker Dosimetry System 2013” were used. Clinical and epidemiology data were obtained from the “Clinic” database. Crude and age-adjusted (by indirect method) incidence and mortality rates for CNS PT per 100000 person-years were calculated. Standardized incidence and mortality trends were analyzed by Jointpoint 4.0.4.
Results: 53 cases and 47 deaths from malignant neoplasms (MN) of brain and spinal cord, cerebral nerve and other parts of CNS (C70–C72 ICD-10 codes) as well as 40 cases and 7 deaths from non-malignant neoplasms (NMN) of brain and other parts of CNS (D-33 ICD-10 code) were identified. CNS MN were more frequent among males (83 %), and CNS NMN were more frequent among females (55 %). Both CNS MN and NMN developed at younger ages among males as compared with females, CNS PT frequency increased with increased attained age. Analysis in relation to calendar period revealed the increasing trend for CNS PT incidence among females only (р=0,008). Effects of chronic occupational radiation exposure on CNS PT incidence and mortality rates were not established either among males or females.
Conclusion: Findings should be considered as preliminary and require further studies.
Keywords: workers, chronic radiation exposure, central nervous system, primary tumors, malignant neoplasms, non-malignant neoplasms
For citation: Moseeva MB, Azizova TV, Bannikova MV. Incidence and Mortality from Central Nervous System Tumors in the Cohort of Workers Chronically Exposed to Radiation. Medical Radiology and Radiation Safety. 2022;67(4):42-48. DOI: 10.33266/1024-6177-2022-67-4-42-48
References
1. Pouchieu C, Gruber A, Berteaud E, Ménégon P, Monteil P, Huchet A, et al. Increasing incidence of central nervous system (CNS) tumors (2000–2012): findings from a population based registry in Gironde (France). BMC Cancer. 2018;18:653. DOI: 10.1186/s12885-018-4545-9.
2. Злокачественные новообразования в России в 2019 году (заболеваемость и смертность). Под ред.: Каприна АД, Старинского ВВ, Шахзадовой АО. М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2020. илл. 252 с. ISBN 978-5-85502-260-5 [Malignant tumors in Russia in 2019 (incidence and moratlity). Eds.: Kaprin AD, Starinskiy VV, Shakhzadovoy AO. M: P. Hertsen MORI – FSBI “NMRRC” of the Ministry of Health of the Russian Federation, 2020. Ill. 252 c. ISBN 978-5-85502-260-5]
3. Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–2017. Neuro-Oncology. 2020;22(S1):1–96. DOI: 10.1093/neuonc/noaa200.
4. Ohgaki H. Epidemiology of Brain Tumors. In: Methods of Molecular Biology, Cancer Epidemiology. Ed.: Verma M. Totowa, NJ, USA: Humana Press, a part of Springer Science + Business Media, 2009, vol. 472, P. 323-342. DOI: 10.1007/978-1-60327-492-0.
5. Khodamoradi F, Ghoncheh M, Pakzad R, Gandomani HS, Salehiniya H. The incidence and mortality of brain and central nervous system cancer and their relationship with human development index in the world. WCRJ. 2017;4(4):e985. DOI: 10.32113/wcrj_201712_985
6. Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il’yasova D, et al. Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer. 2008;113(7 suppl):1953–1968. DOI: 10.1002/cncr.23741.
7. Schlehofer B, Hettinger I, Ryan P, Blettner M, Preston-Martin S, Little J, et al. Occupational risk factors for low grade and high grade glioma: results from an international case control study of adult brain tumours. Int. J. Cancer. 2005;113:116–125. DOI: 10.1002/ijc.20504.
8. Alexiou GA, Kallinteri A, Nita E, Zagorianakou P, Levidiotou S, Voulgaris S. Serum IgE levels in patients with intracranial tumors. Neuroimmunol Neuroinflammation. 2015;2(1):15–17. DOI: 10.4103/2347-8659.149398.
9. Wiedmann MKH, Brunborg C, Di Ieva A, Lindemann K, Johannesen TB, Vatten L, et al. Overweight, obesity and height as risk factors for meningioma, glioma, pituitary adenoma and nerve sheath tumor: a large population-based prospective cohort study. Acta Oncologica. 2017;56(10):1302–1309. DOI: 10.1080/0284186X.2017.1330554.
10. Ostrom QT, Fahmideh MA, Cote DJ, Muskens IS, Schraw JM, Scheurer ME, et al. Risk factors for childhood and adult primary brain tumors. Neuro-Oncology. 2019;21(11):1357–1375. DOI: 10.1093/neuonc/noz123.
11. Radiation Protection Dosimetry. Special issue. 2017;176(1–2).
12.Третьяков ФД. Характеристика радиационной обстановки на плутониевом производстве ПО «Маяк» в разные периоды его деятельности. В: Источники и эффекты облучения работников ПО «Маяк» и населения, проживающего в зоне влияния предприятия. Науч. ред.: Романов СА, Киселев МФ. Озерск: б. и., 2009; Ч. 1:4–50. [Tretyakov FD. Characteristics of the radiation environment at the Maya PA plutonium production plant during different periods of its activity. Eds.: Romanov SA, Kiselev MF. Ozyorsk: without p.h., 2009; P1:4–50.]
13. Третьяков Ф.Д., Романов С.А. Характеристика радиационной обстановки на первом радиохимическом заводе ПО «Маяк». В: Источники и эффекты облучения работников ПО «Маяк» и населения, проживающего в зоне влияния предприятия. Науч. ред.: Киселев МФ, Романов СА. Челябинск: Челябинский дом печати, 2010; Ч. 2:8–34. [Tretyakov FD, Romanov SA. Characteristics of the radiation environment at the first Maya PA radiochemical plant. Eds.: Romanov SA, Kiselev MF. Ozyorsk: without p.h., 2009; P1:4–50.]
14. Koshurnikova NA, Shilnikova NS, Okatenko PV. Characteristics of the cohort of workers at the Mayak nuclear complex. Radiat Res. 1999; 152(4):352–363. PMID: 10477912
15. Азизова ТВ, Тепляков ИИ, Григорьева ЕС, Власенко ЕВ, Сумина МВ, Дружинина МБ, и др. Медико-дозиметрическая база данных «Клиника» работников ПО «Маяк» и их семей. Мед. радиология и радиационная безопасность. 2009; 54(5): 26–35. [Azizova TV, Teplyakov II, Grigorieva EU, Vlasenko EV, Sumina MV, Druzhinina MB, et al. Medical dosimetric database «Clinic» of employees OF PA «Mayak» and their families. Medical Radiology аnd Radiation Safety. 2009;54(5):26-35. (In Russ.)]
16. Мерков АМ, Поляков ЛЕ. Санитарная статистика Пособие для врачей. М.: Атомиздат; 1975. 245 с.[Merkov AM, Polyakov LE. Sanitary statistics M.1975.245pp.(In Russ.)]
17. Joinpoint Trend Analysis Software. [https://surveillance.cancer.gov/joinpoint/ дата обращения 23.03.2022].
18. Международная классификация болезней 10-го пересмотра (МКБ-10) [https://mkb-10.com/ дата обращения 01.02.2021]
19. Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018. Neuro-Oncology. 2021; 23(S3):iii1–iii105. DOI: 10.1093/neuonc/noab200.
20. Qu S, Gao J, Tang B, Yu B, Shen YP, Tu Y. Low-dose ionizing radiation increases the mortality risk of solid cancers in nuclear industry workers: a meta-analysis. Molecular and clinical oncology. 2018; 8:703–711. DOI: 10.3892/mco.2018.1590
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 15.03.2022. Accepted for publication: 11.05.2022
Medical Radiology and Radiation Safety. 2022. Vol. 67. № 4
X-ray Estimation of Structural-topographic Parameters of the Tempo-low Jaund
Joint After Orthognic Surgical Treatment of Dental Jaws with Condition
M.A. Mokhirev, O.S. Kaganova, V.N. Olesova, V.I. Ermolin, E.E. Olesov, A.A. Ilyin
A.I. Burnasyan Federal Medical Biophysical Center, Moscow, Russia.
Contact person: Olesova Valentina Nikolaevna, This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: Using the methods of radiation diagnostics, to trace in dynamics the structural and topographic state of the temporomandibular joint (TMJ) before and after orthognathic treatment of patients with air conditioning
Material and Methods: A CT analysis of the TMJ condition was carried out before and after orthodontic surgical removal of the dentofacial anomaly (skeletal form) with the effects of Candyline resorption. We used the method of Fadeev R.A. et al. to assess the TMJ parameters: height of the head of the lower jaw; anterior and posterior articular angle; the width of the joint space in the upper, anterior, posterior, mesial and lateral sections; maximum width of the head of the lower jaw; density of cortical and cancellous bones of the head of the lower jaw; height of the articular fossa; the length of the anterior slope of the articular fossa; angle of the anterior slope of the articular fossa; the length of the posterior slope of the articular fossa; angle of the posterior slope of the articular fossa.
Results: Comparison of CT parameters of TMJ before and after orthognathic treatment reveals a positive trend in remodeling of the articular process of the lower jaw after surgery, as evidenced by a noticeable increase in the width of the head of the lower jaw with a slight decrease in its height. The absence of compression in the bilaminar zone of the TMJ is recorded due to an increase in the width of the joint space in the posterior section, although the width of the joint space in the upper and anterior sections still does not correspond to normal values. The preservation of a lower density of the cortical and spongy layers of the articular head in comparison with the norm is apparently associated with continued adaptation to the new position of the articular processes and changed functional loads.
Conclusion: A comprehensive orthodontic and surgical approach to the elimination of dentoalveolar anomalies is effective and can be recommended in the treatment of patients with skeletal anomalies and condyloresorption, as it provides not only a significant improvement in facial aesthetic parameters, but also has a positive effect on the structural and topographic parameters of the temporomandibular joint.
Keywords: maxillofacial anomaly, temporomandibular joint, orthognathic surgery, computed tomography, condition dynamics
For citation: Mokhirev MA, Kaganova OS, Olesova VN, Ermolin VI, Olesov EE, Ilyin AA. X-ray Estimation of Structural-topographic Parameters of the Tempo-low Jaund Joint After Orthognic Surgical Treatment of Dental Jaws with Condition. Medical Radiology and Radiation Safety. 2022;67(4):57-61. DOI: 10.33266/1024-6177-2022-67-4-57-61
References
1. Shipika D.V. Sovershenstvovaniye Diagnostiki i Lecheniya Zabolevaniy VNCHS u Patsiyentov s Anomaliyami Prikusa = Improving the Diagnosis and Treatment of TMJ Diseases in Patients with Malocclusion. Extended abstract of candidate’s thesis in Medicine. Moscow Publ., 2012. 26 p. (In Russ.).
2. Hwi-Dong J., Sang Yoon K., Hyung-Sik P., Young-Soo J. Orthognathic Surgery and Temporomandibular Joint Symptoms. Maxillofacial Plastic and Reconstructive Surgery. 2015;37:14.
3. Dujoncquoy J.P., Ferri J., Raoul G., Kleinheinz J. Temporomandibularjoint Dysfunction and Orthognathic Surgery: a Retrospective Study. HeadFace Med. 2010;27:6.
4. Kreutziger K.L., Mahan P.E. Temporomandibular Degenerative Joint Diseas. Oral Surgery Oral Medicine and Oral Pathology. 1975;40;2:165–168.
5. Anuna Laila Mathew, Amar A. Sholapurkar, and Keerthilatha M. Pai Condylar Changes and Its Association with Age, TMD, and Dentition Status: A Cross-Sectional Study. Int. J. Dent. 2011:1-7.
6. Fadeev R.A., Zotova N.Yu., Kuzakova A.V. Method for Examining the Temporomandibular Joints Using Dental Computed Tomography. Institut Stomatologii = The Dental Institute. 2011;4:34-36 (In Russ.).
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The author declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors
Article received: 20.04.2022. Accepted for publication: 25.05.2022
Medical Radiology and Radiation Safety. 2022. Vol. 67. № 4
Magnetic Resonance Imaging of Primary Extra-Axial Intracranial Tumors:
Diagnostic Problems and Prospects of Radiomics
А.V. Kapishnikov1, E.N. Surovcev1,2, Yu.D. Udalov3
1Samara State Medical University, Samara, Russia.
2Treatment and Diagnostic Center of the International Institute of Biological Systems named after Sergey Berezin, Tolyatti, Russia.
3Federal Scientific Clinical Center for Medical Radiology and Oncology, Dimitrovgrad, Russia.
Contact person: Kapishnikov Aleksandr Viktorovich: This email address is being protected from spambots. You need JavaScript enabled to view it.
CONTENTS
Introduction
MRI semiotics in the differential diagnosis of primary extra-axial intracranial tumors (PEIT)
Localization of the tumor and its relationship with the anatomical structures
Heterogeneity (heterogeneity) of the tumor
Tumor margins and peritumoral edema
Apparent diffusion coefficient (ADC)
Dural tail sign
Information technology for MRI analysis and radiomics
Radiomics in differential diagnosis of PEIT
Conclusion
Keywords: magnetic resonance imaging, primary extra-axial intracranial tumors, meningiomas, radiomics, information technology.
For citation: Kapishnikov АV, Surovcev EN, Udalov YuD. Magnetic Resonance Imaging of Primary Extra-Axial Intracranial Tumors: Diagnostic Problems and Prospects of Radiomics. Medical Radiology and Radiation Safety. 2022;67(4):49-56. DOI: 10.33266/1024-6177-2022-67-4-49-56
References
1. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger DL, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
2. Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DCL, et al. EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol. 2021 Jun 28:noab150. doi: 10.1093/neuonc/noab150.
3. Goldbrunner R, Weller M, Regis J, Lund-Johansen M, Stavrinou P, Reuss D, et al. EANO guideline on the diagnosis and treatment of vestibular schwannoma. Neuro Oncol. 2020;22(1):31-45. doi:10.1093/neuonc/noz153.
4. Shin DW, Kim JH, Chong S, Song SW, Kim YH, Cho YHL, et al. Intracranial solitary fibrous tumor/hemangiopericytoma: tumor reclassification and assessment of treatment outcome via the 2016 WHO classification. J Neurooncol. 2021 Sep;154(2):171-178. doi: 10.1007/s11060-021-03733-7.
5. Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. Neuro Oncol. 2019 Nov 1;21(Suppl 5):v1-v100. doi: 10.1093/neuonc/noz150.
6. Fountain DM, Young AMH, Santarius T. Malignant meningiomas. Handb Clin Neurol. 2020;170:245-250. doi:10.1016 /B978-0-12-822198-3.00044-6.
7. Осборн А. Г., Зальцман К. Л., Завери М. Д. Лучевая диагностика. Головной мозг. М.: Издательство Панфилова, 2018. 1216 с. [Osborn А.G., Zalcman К.L., Zaveri M.D. Radiology. Brain. Moscow, Panfilova Publishing House, 2018. 420p. (in Russ.)]
8. Yeole U, Rao KVLN, Beniwal M, Sivakoti S, Santosh V, Somanna S. Cranial and Spinal Malignant Peripheral Nerve Sheath Tumor: A Pathological Enigma. J Neurosci Rural Pract. 2021 Sep 28;12(4):770-779. doi: 10.1055/s-0041-1735325.
9. Islim AI, Mohan M, Moon RDC, Rathi N, Kolamunnage-Dona R, Crofton A, et al. Treatment Outcomes of Incidental Intracranial Meningiomas: Results from the IMPACT Cohort. World Neurosurg. 2020;138:e725-e735. doi:10.1016/j.wneu.2020.03.060.
10. McNeill KA. Epidemiology of Brain Tumors. Neurol Clin. 2016;34(4):981-998. doi:10.1016/j.ncl.2016.06.014.
11. Sun SQ, Cai C, Murphy RK, DeWees T, Dacey RG, Grubb RL, et al. Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection [published correction appears in Neurosurgery. 2014 Dec;75(6):733]. Neurosurgery. 2014;75(4):356-363. doi:10.1227 /NEU.0000000000000462.
12. Laviv Y, Thomas A, Kasper EM. Hypervascular Lesions of the Cerebellopontine Angle: The Relevance of Angiography as a Diagnostic and Therapeutic Tool and the Role of Stereotactic Radiosurgery in Management. A Comprehensive Review. World Neurosurg. 2017;100:100–17.
13. Roos DE, Patel SG, Potter AE, Zacest AC. When is an acoustic neuroma not an acoustic neuroma? Pitfalls for radiosurgeons. J Med Imaging Radiat Oncol. 2015;59(4):474-479. doi:10.1111 /1754-9485.12328.
14. Alatriste-Martínez S, Moreno-Jiménez S, Gutiérrez-Aceves GA, Suárez-Campos JJ, García-Garduño OA, Rosas-Cabral A, et al. Linear Accelerator-Based Radiosurgery of Grade I Intracranial Meningiomas. World Neurosurg X. 2019;3:100027. Published 2019 Mar 7. doi:10.1016/j.wnsx.2019.100027.
15. Gihr GA, Horvath-Rizea D, Kohlhof-Meinecke P, Ganslandt O, Henkes H, Richter C, et al. Histogram Profiling of Postcontrast T1-Weighted MRI Gives Valuable Insights into Tumor Biology and Enables Prediction of Growth Kinetics and Prognosis in Meningiomas. Transl Oncol. 2018;11(4):957-961. doi:10.1016 /j.tranon.2018.05.009.
16. Shabani S, Kaushal M, Kaufman B, Knipstein J, Lawlor MW, Lew S, et al. Intracranial Extraskeletal Mesenchymal Chondrosarcoma: Case Report and Review of the Literature of Reported Cases in Adults and Children. World Neurosurg. 2019;129:302-310. doi:10.1016/j.wneu.2019.05.221.
17. Dunn IF, Bi WL, Mukundan S, Delman BN, Parish J, Atkins T, et al. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Imaging in the Diagnosis and Management of Patients With Vestibular Schwannomas. Neurosurgery. 2018;82(2):E32-E34. doi:10.1093/neuros/nyx510.
18. Stone JA, Cooper H, Castillo M, Mukherji SK. Malignant schwannoma of the trigeminal nerve. AJNR Am J Neuroradiol. 2001;22(3):505-507.
19. Ohba S, Murayama K, Nishiyama Y, Adachi K, Yamada S, Abe M, et al. Clinical and Radiographic Features for Differentiating Solitary Fibrous Tumor/Hemangiopericytoma From Meningioma. World Neurosurg. 2019;130:e383-e392. doi:10.1016/j.wneu .2019.06.094.
20. Lin BJ, Chou KN, Kao HW, Lin C, Tsai WC, Feng SW, et al. Correlation between magnetic resonance imaging grading and pathological grading in meningioma. J Neurosurg. 2014;121(5):1201-1208. doi:10.3171/2014.7 .JNS132359.
21. Ranabhat K, Bishokarma S, Agrawal P, Shrestha P, Panth R, Ghimire RK. Role of MR Morphology and Diffusion-Weighted Imaging in the Evaluation of Meningiomas: Radio-Pathologic Correlation. JNMA J Nepal Med Assoc. 2019;57(215):37-44.
22. Adeli A, Hess K, Mawrin C, Streckert EMS, Stummer W, Paulus W, et al. Prediction of brain invasion in patients with meningiomas using preoperative magnetic resonance imaging. Oncotarget. 2018;9(89):35974-35982. Published 2018 Nov 13. doi:10.18632/oncotarget.26313.
23. Bečulić H, Skomorac R, Jusić A, Alić F, Mašović A, Burazerović E, et al. Correlation of peritumoral brain edema with morphological characteristics and Ki67 proliferative index in resected intracranial meningiomas. Acta Clin Croat. 2019;58(1):42-49. doi:10.20471 /acc.2019.58.01.06.
24. Berhouma M, Jacquesson T, Jouanneau E, Cotton F. Pathogenesis of peri-tumoral edema in intracranial meningiomas. Neurosurg Rev. 2019;42(1):59-71. doi:10.1007/s10143-017-0897-x.
25. Lu Z, You Z, Xie D, Wang Z. Apparent diffusion coefficient values in differential diagnosis and prognostic prediction of solitary of fibrous tumor/hemangiopericytoma (WHOII) and atypical meningioma. Technol Health Care. 2019;27(2):137-147. doi:10.3233 /THC-181447.
26. Shankar JJS, Hodgson L, Sinha N. Diffusion weighted imaging may help differentiate intracranial hemangiopericytoma from meningioma. J Neuroradiol. 2019;46(4):263-267. doi:10.1016 /j.neurad.2018.11.002.
27. El-Ali AM, Agarwal V, Thomas A, Hamilton RL, Filippi CG. Clinical metric for differentiating intracranial hemangiopericytomas from meningiomas using diffusion weighted MRI. Clin Imaging. 2019;54:1-5. doi:10.1016/j.clinimag.2018.10.018.
28. Takeguchi T, Miki H, Shimizu T, Kikuchi K, Mochizuki T, Ohue S, et al. The dural tail of intracranial meningiomas on fluid-attenuated inversion-recovery images. Neuroradiology. 2004;46(2):130-135. doi:10.1007 /s00234-003-1152-4.
29. Aerts HJ. The Potential of Radiomic-Based Phenotyping in Precision Medicine: A Review. JAMA Oncol. 2016 Dec 1;2(12):1636-1642. doi: 10.1001/jamaoncol.2016.2631. PMID: 27541161.
30. Larue RT, Defraene G, De Ruysscher D, Lambin P, van Elmpt W. Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures. Br J Radiol. 2017;90(1070):20160665. doi:10.1259/bjr.20160665.
31. Liu Z, Wang S, Dong D, Wei J, Fang C, Zhou X, et al. The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges. Theranostics. 2019;9(5):1303-1322. Published 2019 Feb 12. doi:10.7150 /thno.30309.
32. Armato SG 3rd, McLennan G, Bidaut L, McNitt-Gray MF, Meyer CR, Reeves AP, et al. The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): a completed reference database of lung nodules on CT scans. Med Phys. 2011;38(2):915-931. doi:10.1118/1.3528204.
33. van Velden FH, Kramer GM, Frings V, Nissen IA, Mulder ER, de Langen AJ, et al. Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation. Mol Imaging Biol. 2016;18(5):788-795. doi:10.1007/s11307-016-0940-2.
34. Parmar C, Rios Velazquez E, Leijenaar R, Jermoumi M, Carvalho S, Mak RH, et al. Robust Radiomics feature quantification using semiautomatic volumetric segmentation. PLoS One. 2014;9(7):e102107. Published 2014 Jul 15. doi:10.1371 /journal.pone.0102107.
35. Liu Y, Kim J, Qu F, Liu S, Wang H, Balagurunathan Y, et al. CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma. Radiology. 2016;280(1):271-280. doi:10.1148/radiol.2016151455.
36. Scalco E, Rizzo G. Texture analysis of medical images for radiotherapy applications. Br J Radiol. 2017;90(1070):20160642. doi:10.1259/bjr.201 60642.
37. Soni N, Priya S, Bathla G. Texture Analysis in Cerebral Gliomas: A Review of the Literature. AJNR Am J Neuroradiol. 2019 Jun;40(6):928-934. doi: 10.3174/ajnr.A6075.
38. Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749-762. doi:10.1038/nrclinonc.2017.141.
39. He L, Huang Y, Ma Z, Liang C, Liang C, Liu Z. Effects of contrast-enhancement, reconstruction slice thickness and convolution kernel on the diagnostic performance of radiomics signature in solitary pulmonary nodule. Sci Rep. 2016;6:34921. Published 2016 Oct 10. doi:10.1038/srep34921.
40. Savio SJ, Harrison LC, Luukkaala T, Heinonen T, Dastidar P, Soimakallio S, et al. Effect of slice thickness on brain magnetic resonance image texture analysis. Biomed Eng Online. 2010;9:60. Published 2010 Oct 18. doi:10.1186/1475-925X-9-60.
41. Yang F, Dogan N, Stoyanova R, Ford JC. Evaluation of radiomic texture feature error due to MRI acquisition and reconstruction: A simulation study utilizing ground truth. Phys Med. 2018;50:26-36. doi:10.1016 /j.ejmp.2018.05.017.
42. Tustison NJ, Avants BB, Cook PA, Zheng Y, Egan A, Yushkevich PA, et al. N4ITK: improved N3 bias correction. IEEE Trans Med Imaging. 2010;29(6):1310-1320. doi:10.1109/TMI.2010.2046908.
43. Waugh SA, Purdie CA, Jordan LB, et al. Magnetic resonance imaging texture analysis classification of primary breast cancer. Eur Radiol. 2016;26(2):322-330. doi:10.1007/s00330-015-3845-6.
44. Park YW, Oh J, You SC, Han K, Ahn SS, Choi YS, et al. Radiomics and machine learning may accurately predict the grade and histological subtype in meningiomas using conventional and diffusion tensor imaging. Eur Radiol. 2019;29(8):4068-4076. doi:10.1007 /s00330-018-5830-3.
45. Laukamp KR, Shakirin G, Baeßler B, Thiele F, Zopfs D, Große Hokamp N, et al. Accuracy of Radiomics-Based Feature Analysis on Multiparametric Magnetic Resonance Images for Noninvasive Meningioma Grading. World Neurosurg. 2019;132:e366-e390. doi:10.1016/j.wneu.2019.08.148.
46. Lu Y, Liu L, Luan S, Xiong J, Geng D, Yin B. The diagnostic value of texture analysis in predicting WHO grades of meningiomas based on ADC maps: an attempt using decision tree and decision forest. Eur Radiol. 2019; 29(3):1318-1328. doi:10.1007/s00330-018-5632-7.
47. Yan PF, Yan L, Hu TT, Xiao DD, Zhang Z, Zhao HY, et al. The Potential Value of Preoperative MRI Texture and Shape Analysis in Grading Meningiomas: A Preliminary Investigation. Transl Oncol. 2017;10(4):570-577. doi:10.1016/j.tranon.2017.04.006.
48. Chen C, Guo X, Wang J, Guo W, Ma X, Xu J. The Diagnostic Value of Radiomics-Based Machine Learning in Predicting the Grade of Meningiomas Using Conventional Magnetic Resonance Imaging: A Preliminary Study. Front Oncol. 2019;9:1338. Published 2019 Dec 6. doi:10.3389/fonc.2019.01338.
49. Ke C, Chen H, Lv X, Li H, Zhang Y, Chen M, et al. Differentiation Between Benign and Nonbenign Meningiomas by Using Texture Analysis From Multiparametric MRI. J Magn Reson Imaging. 2020;51(6):1810-1820. doi:10.1002/jmri.26976.
50. Chu H, Lin X, He J, Pang P, Fan B, Lei P, et al. Value of MRI Radiomics Based on Enhanced T1WI Images in Prediction of Meningiomas Grade. Acad Radiol. 2021;28(5):687-693. doi:10.1016 /j.acra.2020.03.034.
51. Li X, Lu Y, Xiong J, Wang D, She D, Kuai X, et al. Presurgical differentiation between malignant haemangiopericytoma and angiomatous meningioma by a radiomics approach based on texture analysis. J Neuroradiol. 2019;46(5):281-287. doi:10.1016/j.neurad.2019.05.013.
52. Kanazawa T, Minami Y, Jinzaki M, Toda M, Yoshida K, Sasaki H. Preoperative Prediction of Solitary Fibrous Tumor/Hemangiopericytoma and Angiomatous Meningioma Using Magnetic Resonance Imaging Texture Analysis. World Neurosurg. 2018;120:e1208-e1216. doi:10.1016 /j.wneu.2018.09.044.
53. He W, Xiao X, Li X, Guo Y, Guo L, Liu X, et al. Whole-tumor histogram analysis of apparent diffusion coefficient in differentiating intracranial solitary fibrous tumor/hemangiopericytoma from angiomatous meningioma. Eur J Radiol. 2019;112:186-191. doi:10.1016/j.ejrad.2019.01.023.
54. Nagano H, Sakai K, Tazoe J, Yasuike M, Akazawa K, Yamada K. Whole-tumor histogram analysis of DWI and QSI for differentiating between meningioma and schwannoma: a pilot study. Jpn J Radiol. 2019;37(10):694-700. doi:10.1007/s11604-019-00862-y.
55. Gu H, Zhang X, di Russo P, Zhao X, Xu T. The Current State of Radiomics for Meningiomas: Promises and Challenges. Front Oncol. 2020;10:567736. Published 2020 Oct 27. doi:10.3389 /fonc.2020.567736.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The author declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors
Article received: 20.04.2022. Accepted for publication: 25.05.2022
Medical Radiology and Radiation Safety. 2022. Vol. 67. № 4
Three-Color FISH Method: Translocations in Peripheral Blood Lymphocytes Cultures before and after Local Gamma Radiation for Breast Cancer
V.Yu. Nugis, T.A. Astrelina, V.A. Nikitina, M.G. Kozlova,
I.V. Kobzeva, E.E. Lomonosova, Yu.B. Suchkova,
D.Yu. Usupzhanova, V.A. Brunchukov, A.A. Rastorgueva,
T.F. Malivanova, V.A. Brumberg,T.V. Karaseva, E.S. Lyubaeva,
D.Yu. Bobrov, N.G. Stepanyants, M.Yu. Sukhova, A.S. Samoilov
A.I. Burnasyan Federal Medical Biophysical Center of FMBA of Russia, Moscow, Russia
Контактное лицо: Nugis V.Yu., E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: Study of chromosomal aberration yields with a three-color FISH method in the peripheral blood lymphocyte cultures of patients with breast cancer before and after local irradiation.
Material and methods: Venous blood was obtained from 24 patients aged from 33 to 79 years which suffering from cancer of the left or right breast after the implementation of a sectoral or radical resection of an affected organ with subsequent local adjuvant distant radiation therapy (DRT) to the scar area. Also it could be preceded by adjuvant polychimotherapy (PCT). A linear accelerator of the Trilogy system based on the Clinac iX platform was used for local irradiation. SOD was installed at 50 Gy per 25 fractions (daily 2 Gy). venous blood sampling produced to PCT and/or DRT and after 1 and/or 3 months after irradiation. A set of DNA probes to 1, 4 and 12 pairs of chromosomes was used for three-color FISH staining.
Results: Levels of translocations, dicentrics and acentrics (per 100 cells) in peripheral blood lymphocyte cultures of patients up to DRT did not differ significantly with and without PCT and were amounted to average 0.63 ± 0.10; 0.10 ± 0.04 and 0.17 ± 0.06, respectively. The frequency of these chromosome rearrangements significantly increased after radiation therapy by an average of up to 4.62 ± 0.46; 1.48 ± 0.19 and 0.95 ± 0.14. The differences between 1 and 3 months of taking material after irradiation were absent. One of the patients, unlike the rest, was cytogenetically examined 11 years after a similar local irradiation, and the frequencies of translocations and dicentrics in her lymphocyte culture were 4.56 and 0.19 (per 100 cells), respectively, while they were varied from 1.63 to 10.00 for translocations and from 0.27 (0 in one patient) to 4.06 for dicentrics for other patients.
Conclusion: When using a three-color FISH method there was a significant increase in the frequencies of translocations, dicentrics and acentrics in peripheral blood lymphocyte cultures of patients after DRT of breast cancer. At the same time there were more translocations than dicentrics and, apparently, they remain at the initial level for a long time. The frequency of translocations per 1 cell with translocations in the peripheral blood lymphocyte cultures in most cases exceeds 1 after local DRT of the breast cancer. The correlation between average physical doses to the whole body and cytogenetical estimates in individual patients was statistically insignificant.
Keywords: peripheral blood lymphocytes culture, three-color FISH method, translocations, breast cancer, local gamma-irradiation
For citation: Nugis VYu, Astrelina TA, Nikitina VA, Kozlova MG, Kobzeva IV, Lomonosova EE, Suchkova YuB, Usupzhanova DYu, Brunchukov VA, Rastorgueva AA, Malivanova TF, Brumberg VA, Karaseva TV, Lyubaeva ES, Bobrov DYu, Stepanyants NG, Sukhova MYu, Samoilov AS. Three-Color FISH Method: Translocations in Peripheral Blood Lymphocytes Cultures before and after Local Gamma Radiation for Breast Cancer. Medical Radiology and Radiation Safety. 2022;67(4):62-68. DOI: 10.33266/1024-6177-2022-67-4-62-68
References
1. Cytogenetic Dosimetry: Applications in Preparedness for and Response to Radiation Emergencies. Vienna: IAEA, 2011. 240 p.
2. Нугис В.Ю. Прогноз пострадиационной динамики числа нейтрофилов крови в случаях острого неравномерного облучения (цитогенетические исследования). Радиационная биология. Радиоэкология. 2018;58(5):498-510. [Nugis VYu. Prognosis of dynamics of radiation-induced blood neutrophil count according to the results of cytogenetic research of the peripheral blood lymphocyte cultures in cases of acute non-uniform exposures (cytogenetic investigations). Radiation biology. Radioecology. 2018;58(5):498-510. (in Russ.)]. DOI: 10.1134/S0869803118040112.
3. Гузеев Г.Г., Севанькаев А.В., Байсоголов Г.Д. Хромосомные аберрации в лимфоцитах периферической крови после лучевой терапии. Медицинская радиология. 1974;19(9):36-39. [GuzeevGG, Sevan’kaevAV, BaisogolovGD. Chromosome aberrationsin lymphocytes of peripheral blood after radiation therapy. Meditsinskaia Radiologia. 1974;19(9):36-39.(in Russ.)].
4. Mельников А.А., Великая В.В., Уразова Л.Н., Мусабаева Л.И., Лебедев И.Н., Чойнзонов Е.Л. Цитогенетические эффекты лучевой терапии у больных злокачественными новообразованиями. Медицинская генетика. 2011;10(12):3-13. [MelnikovAA, VelikayaVV, UrazovaLN, MusabaevaLI, LebedevIN, ChoinzonovEL. Cytogenetic effects of radiotherapy in cancer patients. Medical Genetics. 2011;10(12):3-13. (in Russ.)].
5. Хвостунов И.К., Курсова Л.В., Шепель Н.Н., Рагулин Ю.А., Севанькаев А.В., Гулидов И.А. и др. Оценка целесообразности применения биологической дозиметрии на основе анализа хромосомных аберраций в лимфоцитах крови больных раком легкого при терапевтическом фракционированном γ-облучении. Радиационная биология. Радиоэкология. 2012;52(5):467-480. [KhvostunovIK, KursovaLV, ShepelNN, RagulunYuA, Sevan’kaevAV, GulidovIA, etal. The estimation of appropriateness of chromosomal aberrations assay as a biological dosimetry based on cytogenetic investigation of lung cancer patients given non-uniform fractional exposures to high doses of therapeutic 60Co γ-rays. Radiation biology. Radioecology.2012;52(5):467-480.(in Russ.)].
6. Хвостунов И.К., Курсова Л.В., Севанькаев А.В., Рагулин Ю.А., Шепель Н.Н., Коровчук О.Н. и др. Радиация и риск. 2019;28(2):87-101. [KhvostunovIK, KursovaLV, Sevan’kaevAV, RagulunYuA, ShepelNN, KorovchukON, etal. The estimation of radiation effect to cancer patients treated with beam-therapy by means of analysis of chromosomal aberrations in blood lymphocytes. Radiation and risk. 2019;28(2):87-101.(in Russ.)].DOI: 10.21870/0131-3878-2019-28-2-87-101.
7. Gamulin M, Kopjar N, Grgic M, Ramik S, Bisof V, Garaj-Vrhovac V. Genome damage in oropharyngeal cancer patients treated by radiotherapy. Croat Med J. 2008;49(4):515-527. DOI: 10.3325/cmj.2008.4.515.
8. Gamulin M, Kopjar N, Grgic M, Ramik S, Viculin T, Petkovic M, Garaj-Vrhovac V. Cytogenetic follow-up in testicular seminoma patients exposed to adjuvant radiotherapy. Coll Antopol. 2010;34(2):455-465.
9. Hille A, Hofman-Hüther H, Kühnle E, Wilken B, Rave-Fränk M, Schmidberger H, Virsik P. Spontaneous and radiation-induced chromosomal instability and persistence of chromosome aberrations after radiotherapy in lymphocytes from prostate cancer patients. Radiat Environ Biophys. 2010;49(1):27–37. DOI: 10.1007/s00411-009-0244-x.
10. Lee Y, Kang J-K, Lee YH, Yoon HJ, Yang SS, Kim SH, et al. Chromosome aberration dynamics in breast cancer patients treated with radiotherapy: Implications for radiation biodosimetry. Mutation Research – Genetic Toxicology and Environmental Mutagenesis. 2021;872:503419. DOI: 10.1016/j.mrgentox.2021.503419.
11. Leonard A, Decat D, Leonard ED, Wambersie A, Renard J. Chromosome aberrations in patients irradiated for pelvic tumours. Strahlentherapie und Onkologie. 1987;163(12):795-799.
12. Leonard A, Gerber GB. Chromosome aberrations as biological indicators for radiation damage following partial body irradiation. bga-Schriften. 1986;2:261-262.
13. Matsubara S, Sasaki MS, Adachi T. Dose response relationship of lymphocyte chromosomes in locally irradiated persons. J Radiat Res. 1974;15(4):189-196.DOI: 10.1269/jrr.15.189.
14. Manivannan B, Kuppusamy T, Venkatesan S, Perumal V. A comparison of estimates of doses to radiotherapy patients obtained with the dicentric chromosome analysis and the γ-H2AX assay: Relevance to radiation triage. Applied Radiation and Isotops. 2018;131:1-7. DOI: 10.1016/j.apradiso.2017.10.031.
15. Matsuoka A, Yamada K, Hayashi M, Sofuni T. Chromosomal aberrations detected by chromosome painting in lymphocytes from cancer patients given high doses of therapeutic X-rays. J Radiat Res. 1996;37(4):257-265. DOI: 10.1269/jrr.37.257.
16. Roch-Lefèvre S, Pouzoulet F, Giraudet AL, Voisin Pa, Vaurijoux A, Gruel G, et al. Cytogenetic assessment of heterogeneous radiation doses in cancer patients treated with fractionated radiotherapy. The British Journal of Radiology. 2014;83(993):759-766. DOI: 10.1259/bjr/210225597.
17. Senthamizhchelvan S, PantGS, RathGK, JulkaPK, NairO, JoshiRC, etal. Biodosimetry using chromosome aberrations in human lymphocytes. Radiation Protection Dosimetry. 2007;123(2):241-245. DOI: 10.1093/rpd/ncl109.
18. Silva-Barbosa I, Pereira-Magnata S, Amaral A, Sotero G, Melo HC. Dose assessment by quantification of chromosome aberrations and micronuclei in peripheral blood lymphocytes from patients exposed to gamma radiation. Genetics and Molecular Biology. 2005;28(3):452-457.
19. Ломоносова Е.Е., Нугис В.Ю., Снигирёва Г.П., Козлова М.Г., Никитина В.А., Галстян И.А. Цитогенетический анализ культур лимфоцитов периферической крови пациента в отдалённые сроки после аварийного облучения с помощью трехцветного FISH-метода. Радиационная биология. Радиоэкология. 2022;62(1):5-17. [Lomonosova EE, Nugis VYu, Snigiryova GP, Kozlova MG, Nikitina VA, Galstyan IA. Citogenetic analysis peripheral blood lymphocytes cultures of patient in long terms after emergency irradiation with the help of three-color FISH method. Radiation biology. Radioecology. 2022;62(1):5-7. (in Russ.)]. DOI: 10.31857/S0869803122010064.
20. Нугис В.Ю., Снигирёва Г.П., Ломоносова Е.Е., Козлова М.Г., Никитина В.А. Трёхцветный FISH-метод: кривые доза-эффект для транслокаций в культурах лимфоцитов периферической крови после гамма-облучения in vitro. Медицинская радиология и радиационная безопасность. 2020;65(5):12-20. [Nugis VYu, Snigiryova GP, Lomonosova EE, Kozlova MG, Nikitina VA. Three-color FISH method: dose-effect curves for translocations in peripheral blood lymphocyte cultures after gamma-irradiation in vitro. Medical Radiology and Radiation Safety. 2020;65(5):12–20. (in Russ.)]. DOI: 10.12737/1024-6177-2020-65-5-12-20.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Informed Consent
All patients signed an informed consent to participate in the study.
Article received: 11.04.2022. Accepted for publication: 11.05.2022